Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge and Kirkland & Ellis advises Baxter in connection with the acquisition of Gambro
Mandate

Vinge and Kirkland & Ellis advises Baxter in connection with the acquisition of Gambro

December 05, 2012

Vinge and Kirkland & Ellis advises the global medical technology company Baxter International Inc. (“Baxter”) in connection with the acquisition of Gambro AB for an enterprise value of SEK 26.5 billion. Closing of the transaction is subject to applicable competition law approvals and other customary closing conditions.

Vinge acted as local counsel for Baxter. The Vinge team included Johan Winnerblad (partner), Jonas Bergström and Jonas Johansson together with, among others, Nicolina Kindblom, Gustav Jönsson, Rime Dreber, Emma Lindelöf, Daniel Unger, Helena Höök and Evelina Tejle.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026